Oppenheimer initiated coverage of ARS Pharmaceuticals (SPRY) with an Outperform rating and $40 price target As the first and only approved needle-free epinephrine product, neffy has the potential ...

In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report), with a price target of $28.00. The company’s shares ...

NORTHFIELD, Minn., Feb. 4, 2025 /PRNewswire/ -- Aurora Pharmaceutical, a leader in animal health solutions, is proud to announce a 30% expansion of its sales force over the past three years.

Aurora Pharmaceutical logo "Our sales team is the backbone of our customer relationships, and this expansion reflects both our business growth and our dedication to providing best-in-class service to ...

HR+/HER2- breast cancer is the most prevalent subtype of breast cancer, defined by cancer cells that possess hormone ...

Despite these options, the market remains highly dynamic, with major players such as Merck, Arvinas, Olema Pharmaceuticals, Celcuity, Roche, AstraZeneca, Daiichi Sankyo, Eli Lilly, Sermonix ...

LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...

Years of scouring the bush and breeding work at The University of Queensland have resulted in new varieties of a native Australian plant valuable to the global pharmaceutical industry ...